Companies: 10,795·Total market cap: $144.5T
Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCLFOTCHealthcare
$6.25
+$0.66(+11.81%)
Market Cap$96618306
P/E Ratio
52W High$12.5
52W Low$0.88
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Satellos Bioscience Inc. (MSCLF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001421642 · MSCLF · OTC · as of Jun 9, 2026

Filing snapshot

35
Total Filings
6-K
Latest Form
2026-05-27
Most Recent
2012
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001421642 · Updated hourly · Not investment advice

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-05-27
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-20
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-09
View
S-8Employee Stock Plan Registration
FORM S-8
2026-03-27
View
40-F40-F
40-F
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-27
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-10
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-24
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-19
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-12
View
Showing 1–15 of 35 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001421642  |  Exchange: OTC · Healthcare

Satellos Bioscience Inc. (OTC: MSCLF) has submitted 35 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001421642, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Satellos Bioscience Inc.'s most comprehensive regulatory disclosure. The most recent Satellos Bioscience Inc. 10-K was filed on — for fiscal year ending —. Historical MSCLF 10-K annual reports are available from 2007 through —.

Investors researching Satellos Bioscience Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

MSCLF SEC Filings · 8 questions

Satellos Bioscience Inc. (MSCLF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 35 filings and access original documents at no cost. Satellos Bioscience Inc.'s CIK is 0001421642.

MSCLF SEC filingsSatellos Bioscience Inc. SEC documentsfind MSCLF 10-K